Xiaoqing Yu

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Prognostic Factors

Small Cell Lung Cancer

Brain Metastases

Top Venues

Thoracic cancer

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Kai-Yan Chen, Yanjun Xu, Zhiyu Huang, Xiaoqing Yu, Wei Hong, Hui Li, Xiaoling Xu, Hongyang Lu, Fajun Xie, Jun Chen, Youzu Xu, Yun Fan
Sintilimab plus anlotinib as second- or third-line therapy in metastatic non-small cell lung cancer with uncommon epidermal growth factor receptor mutations: A prospective, single-arm, phase II trial. Cancer medicine (2023)
Na Li, Ming-Ying Xie, Zi-Chao Zhou, Jia-Min Sheng, Xiaoqing Yu, Yun Fan
Real-world treatment and prognostic factors for survival in ALK+ non-small cell lung cancer (NSCLC) patients with brain metastases in China. Thoracic cancer (2022)
Xiaoqing Yu, Jinfei Si, Jingwen Wei, Yanling Wang, Yan Sun, Jianan Jin, Xiaoyan Zhang, Tonghui Ma, Zhengbo Song
The effect of EGFR-TKIs on survival in advanced non-small-cell lung cancer with EGFR mutations: A real-world study. Cancer medicine (2022)
Jia-Min Sheng, Hui Li, Xiaoqing Yu, Sizhe Yu, Kai-Yan Chen, Guoqiang Pan, Ming-Ying Xie, Na Li, Zi-Chao Zhou, Yun Fan
Efficacy of PD-1/PD-L1 inhibitors in patients with non-small cell lung cancer and brain metastases: A real-world retrospective study in China. Thoracic cancer 12 (22) (2021)